Supraventricular Tachycardia by Concealed Bypass Tract
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Concealed bypass tract (CBT) results from incomplete development of the atrioventricular (AV) annulus. CBT conducts only in a retrograde direction, and therefore does not cause pre-excitation on standard electrocardiograms. The most common tachycardia associated with CBT is an orthodromic atrioventricular reentrant tachycardia (AVRT): a pathway involving anterograde circuitry through the AV node and His Purkinje system and retrograde conduction over the accessory pathway. Orthodromic AVRT accounts for approximately 90%–95% cases of AVRT. Most incidences of CBT occur at the left free wall. Vagal maneuvers and/or intravenous (IV) adenosine are recommended for first line acute management of AVRT. However, pharmacological therapy with IV diltiazem, verapamil, or beta blockers can also be effective for acute treatment for orthodromic AVRT in patients who do not show pre-excitation on their resting ECG during sinus rhythm. The first-line ongoing therapy for AVRT is catheter ablation of CBT; when catheter ablation is not indicated or preferred, oral beta blockers, diltiazem, verapamil, flecainide, propafenone, or amiodarone are recommended.
Abstract
Concealed bypass tract (CBT) results from incomplete development of the atrioventricular (AV) annulus. CBT conducts only in a retrograde direction, and therefore does not cause pre-excitation on standard electrocardiograms. The most common tachycardia associated with CBT is an orthodromic atrioventricular reentrant tachycardia (AVRT): a pathway involving anterograde circuitry through the AV node and His Purkinje system and retrograde conduction over the accessory pathway. Orthodromic AVRT accounts for approximately 90%–95% cases of AVRT. Most incidences of CBT occur at the left free wall. Vagal maneuvers and/or intravenous (IV) adenosine are recommended for first line acute management of AVRT. However, pharmacological therapy with IV diltiazem, verapamil, or beta blockers can also be effective for acute treatment for orthodromic AVRT in patients who do not show pre-excitation on their resting ECG during sinus rhythm. The first-line ongoing therapy for AVRT is catheter ablation of CBT; when catheter ablation is not indicated or preferred, oral beta blockers, diltiazem, verapamil, flecainide, propafenone, or amiodarone are recommended.
참고문헌 (22)
- Page RL, "2015 ACC", AHA, American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2016[DOI]
- Waxman MB, "Vagal techniques for termination of paroxysmal supraventricular tachycardia", Am J Cardiol, 46, pp.655~664 (1980)
- Lim SH, "Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage", Ann Emerg Med, 31, pp.30~35 (1998)
- Luber S, "Paroxysmal supraventricular tachycardia : outcome after ED care", Ann Emerg Med, 19, pp.40~42 (2001)
- Delaney B, "The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: A meta-analysis", Eur J Emerg Med, 18, pp.148~152 (2011)
- Furlong R, "Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by ems personnel without direct physician control", Am J Emerg Med, 13, pp.383~388 (1995)
- Neumar RW, "Part 8: adult advanced cardiovascular life support:2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care", Circulation, 122, pp.S729~S767 (2010)
- Brady WJ, Jr., "Treatment of out-of-hospital supraventricular tachycardia : adenosine vs verapamil", Acad Emerg Med, 3, pp.574~585 (1996)
- Stec S, "Efficacy of low energy rectilinear biphasic cardioversion for regular atrial tachyarrhythmias", Cardiol J, 18, pp.33~38 (2011)
- DiMarco JP, "Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The adenosine for PSVT study group", Ann Intern Med, 113, pp.104~110 (1990)
- Huycke EC, "Intravenous diltiazem for termination of reentrant supraventricular tachycardia : a placebo-controlled, randomized, double-blind, multicenter study", J Am Coll Cardiol, 13, pp.538~544 (1989)
- Hamer A, "Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome", Am Heart J, 101, pp.600~612 (1981)
- Hombach V, "Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise", Klin Wochenschr, 59, pp.123~133 (1981)
- Calkins H, "Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr multicenter investigators group", Circulation, 99, pp.262~270 (1999)
- Dagres N, "Outcome and use of antiarrhythmic drugs during follow-up", Eur Heart J, 20, pp.1826~1832 (1999)
- Dorian P, "A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. the flecainide multicenter investigators group", Am J Cardiol, 77, pp.89A~95A (1996)
- Sakurai M, "Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia", Am Heart J, 105, pp.619~628 (1983)
- Henthorn RW, "Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The flecainide supraventricular tachycardia study group", Circulation, 83, pp.119~125 (1991)
- Chimienti M, "Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the flecainide and propafenone Italian study (FAPIS)group", Eur Heart J, 16, pp.1943~1951 (1995)
- Cheng CH, "Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia", Ann Intern Med, 133, pp.864~876 (2000)
- Feld GK, "Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome", Am Heart J, 115, pp.102~107 (1988)
- Bauernfeind RA, "Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia", Circulation, 62, pp.1341~1349 (1980)